• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

tirzepatide

Heart-shaped stone in a zen garden
Research

How GLP-1s help the heart relax: study

Giving GLP-1 mimic exendin-4 to rodents with constricted blood vessels caused their capillaries to relax back to a normal state.
Darren Incorvaia Mar 2, 2026 7:01pm
obesity overweight weight loss weigh

Novo's CagriSema loses phase 3 obesity battle against Zepbound

Feb 23, 2026 7:20am
Eli Lillys booth at ASH 2025 prominently featuring Jaypirca

Lilly looks to become innovation ‘backbone,’ exec says

Dec 8, 2025 12:05pm
weight loss scale weigh measure tape obesity overweight

Pfizer’s new prize Metsera touts 14% weight loss for GLP-1

Sep 30, 2025 6:40am
cancel

Lilly withdraws phase 2 obesity trial before starting enrollment

Sep 25, 2025 8:07am
head to head against clash football helmets fight combat

BrightGene tops Novo drug in diabetes ahead of Zepbound showdown

Jun 23, 2025 2:30pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings